Your browser doesn't support javascript.
loading
Management of the axilla in postmenopausal patients with cN0 hormone receptor-positive/HER2-negative breast cancer treated with neoadjuvant endocrine therapy and its prognostic impact.
Garcia-Tejedor, Amparo; Falo, Catalina; Fernandez-Gonzalez, Sergi; Laplana, Maria; Gil-Gil, Miguel; Soler-Monso, Teresa; Martinez-Perez, Evelyn; Calvo, Iris; Calpelo, Hugo; Bajen, Maria-Teresa; Benitez, Ana; Ortega, Raul; Petit, Anna; Guma, Anna; Campos, Miriam; Stradella, Agostina; Lopez-Ojeda, Ana; Ponce, Jordi; Pla, Maria J; Pernas, Sonia.
Afiliação
  • Garcia-Tejedor A; Department of Gynaecology. Multidisciplinary, Breast Cancer Unit. Hospital Universitari Bellvitge, Idibell, Bellvitge Hospital, Ave. Feixa Llarga, sn Hospitalet de Llobregat, 08970, Barcelona, Spain. agarciat@bellvitgehospital.cat.
  • Falo C; Department of Medical Oncology. Multidisciplinary Breast Cancer Unit, Institut Català d'Oncología, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Fernandez-Gonzalez S; Department of Gynaecology. Multidisciplinary, Breast Cancer Unit. Hospital Universitari Bellvitge, Idibell, Bellvitge Hospital, Ave. Feixa Llarga, sn Hospitalet de Llobregat, 08970, Barcelona, Spain.
  • Laplana M; Department of Oncologic Radiotherapy. Multidisciplinary Breast Cancer Unit, Institut Català d'Oncología. IDIBELL, Barcelona, Spain.
  • Gil-Gil M; Department of Medical Oncology. Multidisciplinary Breast Cancer Unit, Institut Català d'Oncología, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Soler-Monso T; Department of Pathology. Multidisciplinary, Breast Cancer Unit. Hospital Universitari Bellvitge, Idibell, Barcelona, Spain.
  • Martinez-Perez E; Department of Oncologic Radiotherapy. Multidisciplinary Breast Cancer Unit, Institut Català d'Oncología. IDIBELL, Barcelona, Spain.
  • Calvo I; Department of Gynaecology. Multidisciplinary, Breast Cancer Unit. Hospital Universitari Bellvitge, Idibell, Bellvitge Hospital, Ave. Feixa Llarga, sn Hospitalet de Llobregat, 08970, Barcelona, Spain.
  • Calpelo H; Department of Gynaecology. Multidisciplinary, Breast Cancer Unit. Hospital Universitari Bellvitge, Idibell, Bellvitge Hospital, Ave. Feixa Llarga, sn Hospitalet de Llobregat, 08970, Barcelona, Spain.
  • Bajen MT; Department of Nuclear Medicine, Multidisciplinary Breast Cancer Unit. Hospital Universitari Bellvitge, Idibell, Barcelona, Spain.
  • Benitez A; Department of Nuclear Medicine, Multidisciplinary Breast Cancer Unit. Hospital Universitari Bellvitge, Idibell, Barcelona, Spain.
  • Ortega R; Department of Radiology. Multidisciplinary, Breast Cancer Unit. Hospital Universitari Bellvitge, Idibell, Barcelona, Spain.
  • Petit A; Department of Pathology. Multidisciplinary, Breast Cancer Unit. Hospital Universitari Bellvitge, Idibell, Barcelona, Spain.
  • Guma A; Department of Radiology. Multidisciplinary, Breast Cancer Unit. Hospital Universitari Bellvitge, Idibell, Barcelona, Spain.
  • Campos M; Department of Gynaecology. Multidisciplinary, Breast Cancer Unit. Hospital Universitari Bellvitge, Idibell, Bellvitge Hospital, Ave. Feixa Llarga, sn Hospitalet de Llobregat, 08970, Barcelona, Spain.
  • Stradella A; Department of Medical Oncology. Multidisciplinary Breast Cancer Unit, Institut Català d'Oncología, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Lopez-Ojeda A; Department of Plastic Surgery. Multidisciplinary, Breast Cancer Unit. Hospital Universitari Bellvitge, Idibell, Barcelona, Spain.
  • Ponce J; Department of Gynaecology. Multidisciplinary, Breast Cancer Unit. Hospital Universitari Bellvitge, Idibell, Bellvitge Hospital, Ave. Feixa Llarga, sn Hospitalet de Llobregat, 08970, Barcelona, Spain.
  • Pla MJ; Department of Gynaecology. Multidisciplinary, Breast Cancer Unit. Hospital Universitari Bellvitge, Idibell, Bellvitge Hospital, Ave. Feixa Llarga, sn Hospitalet de Llobregat, 08970, Barcelona, Spain.
  • Pernas S; Department of Medical Oncology. Multidisciplinary Breast Cancer Unit, Institut Català d'Oncología, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain. spernas@iconcologia.net.
Breast Cancer Res Treat ; 199(3): 445-456, 2023 Jun.
Article em En | MEDLINE | ID: mdl-37043108
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Tipo de estudo: Observational_studies / Prognostic_studies Limite: Aged / Female / Humans Idioma: En Revista: Breast Cancer Res Treat Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Espanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Tipo de estudo: Observational_studies / Prognostic_studies Limite: Aged / Female / Humans Idioma: En Revista: Breast Cancer Res Treat Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Espanha